Literature DB >> 32439955

Effect on metabolic bone disease markers in the neonatal intensive care unit with implementation of a practice guideline.

Elizabeth Marie Sabroske1, Davis Harrison Payne2, Christina Nicole Stine3, Charmaine Marie Kathen4, Heather Marie Sollohub4, Katy Leanne Kohlleppel4, Pamela Louise Lorbieski4, Jennifer Elizabeth Carney4, Cheryl Leah Motta1,4, Maria Rodriguez Pierce1,4, Kaashif Aqeeb Ahmad5,6,7.   

Abstract

OBJECTIVES: To determine the effect of implementing a 2015 policy for the screening, prevention, and management of metabolic bone disease for very low birth weight (VLBW) infants in two Level IV NICUs. STUDY
DESIGN: Retrospective cohort study of VLBW infants in the 2 years prior to (2013-2014) and after (2016-2017) policy implementation.
RESULTS: We identified 316 VLBW infants in 2013-2014 and 292 in 2016-2017 who met study criteria. After policy implementation, vitamin D supplementation began earlier (20.1 ± 15.5 days vs 30.2 ± 20.1 days, p < 0.0005), the percentage of infants with alkaline phosphatase obtained increased (89.7% vs 76.3%, p < 0.0005), while the percentage of infants with alkaline phosphatase >800 IU/L (11.7 vs 4.5%, p = 0.0001) and phosphorous <4 mg/dL (14.2% vs 7.9%, p = 0.014) fell significantly.
CONCLUSIONS: After policy implementation, vitamin D supplementation began significantly earlier and the rate of detecting abnormal biochemical markers of metabolic bone disease decreased significantly.

Entities:  

Year:  2020        PMID: 32439955     DOI: 10.1038/s41372-020-0693-2

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  1 in total

Review 1.  Metabolic bone disease of prematurity.

Authors:  Stacy E Rustico; Andrew C Calabria; Samuel J Garber
Journal:  J Clin Transl Endocrinol       Date:  2014-07-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.